Featured Publications
Oocyte Cryopreservation for Medical and Planned Indications: A Practical Guide and Overview
Han E, Seifer D. Oocyte Cryopreservation for Medical and Planned Indications: A Practical Guide and Overview. Journal Of Clinical Medicine 2023, 12: 3542. PMID: 37240648, PMCID: PMC10218997, DOI: 10.3390/jcm12103542.Peer-Reviewed Original ResearchOocyte cryopreservationAge-related fertility declineOvarian follicular lossFirst successful pregnancyElective oocyte cryopreservationFollicular lossGonadotoxic therapySuccessful pregnancyTreatment of cancerBiologic childrenFollicular fluidOvarian folliclesNarrative reviewMature oocytesOocytesPregnancyPatientsTherapyCancerFollicles
2011
Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women
Aslam MF, Merhi ZO, Ahmed S, Kuzbari O, Seifer DB, Minkoff H. Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women. Fertility And Sterility 2011, 95: 1790-1793. PMID: 21075370, PMCID: PMC3047594, DOI: 10.1016/j.fertnstert.2010.10.033.Peer-Reviewed Original Research
1999
Infertility treatment and informed consent: current practices of reproductive endocrinologists.
Houmard BS, Seifer DB. Infertility treatment and informed consent: current practices of reproductive endocrinologists. Obstetrics And Gynecology 1999, 93: 252-7. PMID: 9932565, DOI: 10.1016/s0029-7844(98)00389-5.Peer-Reviewed Original ResearchConceptsOvulation inductionCurrent practice patternsInfertility treatmentOvarian cancerReproductive endocrinologistsInformed consentIntrauterine inseminationPractice patternsMost physiciansBoard-certified reproductive endocrinologistsReproductive technologiesPatients of risksOvarian cancer riskLength of treatmentLogistic regression analysisMajority of physiciansAssisted Reproductive TechnologyInvasive therapyCancer riskVerbal consentPossible associationEndocrinologistsCancerPhysiciansCommon changesInfertility Treatment and Informed Consent
HOUMARD B, SEIFER D. Infertility Treatment and Informed Consent. Obstetrics And Gynecology 1999, 93: 252-257. DOI: 10.1097/00006250-199902000-00018.Peer-Reviewed Original ResearchOvulation inductionCurrent practice patternsInfertility treatmentOvarian cancerReproductive endocrinologistsInformed consentIntrauterine inseminationPractice patternsMost physiciansBoard-certified reproductive endocrinologistsReproductive technologiesPatients of risksOvarian cancer riskLength of treatmentLogistic regression analysisMajority of physiciansAssisted Reproductive TechnologyInvasive therapyCancer riskVerbal consentPossible associationCancerEndocrinologistsPhysiciansCommon changes
1997
Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer
Lambert-Messerlian GM, Steinhoff M, Zheng W, Canick JA, Gajewski WH, Seifer DB, Schneyer AL. Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer. Gynecologic Oncology 1997, 65: 512-516. PMID: 9190984, DOI: 10.1006/gyno.1997.4719.Peer-Reviewed Original ResearchConceptsEpithelial ovarian cancerPostmenopausal womenCA 125Serum markersOvarian cancerAlpha-inhibin precursorsDimeric inhibin APro-alphaC levelsSerum of womenPreoperative serum levelsGood serum markerInhibin proteinPotential serum markerAlphaC inhibinTotal inhibinInhibin BInhibin secretionSerum levelsInhibin AInhibinNonspecific assaysEOC casesWomenCancerSerum
1986
Critical reassessment of “second-look” exploratory laparotomy in epithelial ovarian cancer. II. Prognostic factors and treatment outcome in patients with persistent cancer
Miller D, Ballon S, Soriero O, Teng N, Seifer D. Critical reassessment of “second-look” exploratory laparotomy in epithelial ovarian cancer. II. Prognostic factors and treatment outcome in patients with persistent cancer. Gynecologic Oncology 1986, 23: 253-254. DOI: 10.1016/0090-8258(86)90256-8.Peer-Reviewed Original Research